scholarly journals Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial

2014 ◽  
Vol 15 (1) ◽  
pp. 69-77 ◽  
Author(s):  
Jason R Westin ◽  
Fuliang Chu ◽  
Min Zhang ◽  
Luis E Fayad ◽  
Larry W Kwak ◽  
...  
Keyword(s):  
Follicular Lymphoma ◽  
Phase 2 ◽  
Single Group ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase ◽  
Pd1 Blockade

scholarly journals Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial

2016 ◽  
Vol 17 (10) ◽  
pp. 1374-1385 ◽  
Author(s):  
Howard L Kaufman ◽  
Jeffery Russell ◽  
Omid Hamid ◽  
Shailender Bhatia ◽  
Patrick Terheyden ◽  
...  
Keyword(s):  
Cell Carcinoma ◽  
Merkel Cell Carcinoma ◽  
Phase 2 ◽  
Merkel Cell ◽  
Single Group ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial

2021 ◽  
Author(s):  
Cornedine J de Gooijer ◽  
Vincent van der Noort ◽  
Jos A Stigt ◽  
Paul Baas ◽  
Bonne Biesma ◽  
...  
Keyword(s):  
Malignant Mesothelioma ◽  
Phase 2 ◽  
First Line ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase ◽  
Line Chemotherapy

Dexamethasone plus oseltamivir versus dexamethasone in treatment-naive primary immune thrombocytopenia: a multicentre, randomised, open-label, phase 2 trial

2021 ◽  
Vol 8 (4) ◽  
pp. e289-e298 ◽  
Author(s):  
Lu Sun ◽  
Juan Wang ◽  
Linlin Shao ◽  
Chenglu Yuan ◽  
Hongguo Zhao ◽  
...  
Keyword(s):  
Immune Thrombocytopenia ◽  
Phase 2 ◽  
Open Label ◽  
Phase 2 Trial ◽  
Primary Immune Thrombocytopenia ◽  
Open Label Phase ◽  
Treatment Naïve

Substitution of ethambutol with linezolid during the intensive phase of treatment of pulmonary tuberculosis: a prospective, multicentre, randomised, open-label, phase 2 trial

2019 ◽  
Vol 19 (1) ◽  
pp. 46-55 ◽  
Author(s):  
Jung-Kyu Lee ◽  
Ji Yeon Lee ◽  
Deog Kyeom Kim ◽  
Ho Il Yoon ◽  
Ina Jeong ◽  
...  
Keyword(s):  
Pulmonary Tuberculosis ◽  
Phase 2 ◽  
Open Label ◽  
Intensive Phase ◽  
Phase 2 Trial ◽  
Open Label Phase

scholarly journals Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

2014 ◽  
Vol 15 (12) ◽  
pp. 1311-1318 ◽  
Author(s):  
Nathan H Fowler ◽  
R Eric Davis ◽  
Seema Rawal ◽  
Loretta Nastoupil ◽  
Fredrick B Hagemeister ◽  
...  
Keyword(s):  
Phase 2 ◽  
Indolent Lymphoma ◽  
Open Label ◽  
Phase 2 Trial ◽  
Open Label Phase
Sign in / Sign up

Export Citation Format

Share Document